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Summary Single-cell electrophoresis (comet assay) has been used to evaluate DNA damage and repair in the human myeloid leukaemia
cell line K562 after low-dose (predominantly sub-lethal) treatments of hyperthermia and photodynamic therapy (PDT). Three different
photosensitizers were examined: haematoporphyrin derivative (HpD), methylene blue (MB) and meso-tetrahydroxyphenylchlorin (mTHPC).
None of the drugs in the absence of light, nor in light alone, resulted in detectable DNA damage. However, a significant amount of DNA
damage was detected immediately after treatment with haematoporphyrin derivative or methylene blue PDT compared with drug-only or light-
only treatments; no residual level of DNA damage was evident for either drug following a 4-h post-treatment incubation at 370C. No significant
DNA damage was detected after meso-tetrahydroxyphenylchlorin PDT or hyperthermia either immediately or 4 h after treatment. We conclude
that the alkaline comet assay can be applied as an effective screening assay for DNA damage induced by a range of laser therapies.
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Lasers are becoming an increasingly important tool in the manage-
ment ofa number ofmedical conditions (Levy, 1995), in particular
cancer. They may be used to produce thermally induced vaporiza-
tion, coagulation or hyperthermia, and non-thermal damage by the
interaction of low-power laser light plus photosensitizing drugs
[photodynamic therapy (PDT)]. PDT is approved forcertain appli-
cations (Brown, 1996), and reports are now being published on the
results of phase I to phase III clinical trials (Marcus, 1992). As
these therapies become more popular, with the arrival of cheaper,
more powerful light sources (Whitehurst and Moore, 1995) and
approved clinical protocols, investigation of the potential long-
term side-effects of these therapies (e.g. mutations as a result of
DNA damage) are likely to become increasingly important.
The toxic species generated upon irradiation of PDT photosen-
sitizers are generally considered to consist of reactive oxygen
species (Bonnet and Berenbaum, 1989). The proposed key species
is singlet oxygen, which is capable ofreaction with a wide variety
of subcellular targets, including DNA (Moan et al, 1989). The
majority of PDT photosensitizers are relatively lipophilic and are
reported to localize predominantly in the cytoplasm or cyto-
plasmic organelles (Moan et al, 1989). As the diffusion distance of
singlet oxygen in a cell is only < 0.075 gm (Moan, 1990). only
limited studies have been performed on the effects of potential
DNA damage and repair during PDT, and new drugs are not
routinely screened for such damage.
A widely used photosensitizer is haematoporphyrin derivative
(HpD). This drug has been subjected to a number of studies, the
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majority ofwhich report some degree ofDNA damage after HpD-
PDT (Blazek and Hariharan, 1984; Boegheim et al, 1987; Penning
et al, 1994a). This contrasts with the evidence from localization
studies of HpD within cells that suggest only 4% ofthe total drug
is in the nuclear fraction (Gomer, 1978), making direct DNA
damage appearunlikely. Methylene blue (MB) is an effective PDT
sensitizer for some bladder cancer cell lines (Fowler et al, 1990)
and a range of viruses including human immunodeficiency virus
(HIV) (Bachmann et al, 1995). A number of reports suggest that
methylene blue photodynamic therapy (MB-PDT) might be
expected to cause DNA damage as MB is known to bind to DNA
(Norden and Tjerneld 1982) and in combination with light medi-
ates 8-hydroxyguanine formation in DNA (Buchko et al, 1995).
However, despite evidence ofgenotoxic effects ofMB plus light in
vitro, this has not been reproduced in vivo (Wagner et al, 1995).
The new sensitizer meso-tetrahydroxyphenylchlorin (mTHPC) is
an effective PDT photosensitizer (Bonnett and Berenbaum, 1989),
but to date no reports relating to potential DNA damage and repair
exist to our knowledge. Confocal scanning laser fluorescence
microscopy studies ofmTHPC in vitro have shown adiffuse distri-
bution ofthe drug in the cytoplasm after a 24-h exposure (Ma et al,
1994), implying DNA damage is unlikely on activation of the
drug. However, as HpD is known to cause some DNA damage
despite poor nuclear localization, the possibility of DNA damage
after mTHPC-PDT should not be excluded purely on the basis of
localization data.
After thermal laser treatments, cells surrounding the treatment
area are exposed to some sublethal doses of hyperthermia. Low-
dose hyperthermia damage is generally considered to cause
protein damage in a wide range of subcellular sites, such as the
membrane (Konings, 1988), cytoskeleton (Welch and Suhan,
1985), mitochondria (Dickson and Calderwood, 1979) or nucleus
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(Welch and' Suhan, 1985), in addition to inhibiting protein
synthesis in a dose-dependent manner (Black and Subjeck, 1989).
Higher levels of heat treatments (45-98°C) induce DNA damage,
such as DNA 'melting' (Lepock and Kruuv, 1992). However, the
lower doses of interest in this study (42-440C) have been associ-
ated with only morphological changes in the nucleus, an increase
in nuclear protein content of the nucleus and functional perturba-
tions in RNA and DNA synthesis (Roti Roti and Laszlo, 1988) but
little direct DNA damage (Warters and Stone, 1983). Based on
these studies, it has been proposed that the nuclear effect of low-
dose heat treatments is related to heat-induced changes in chro-
matin structure and nuclear protein aggregation rather than direct
DNA damage.
The recently developed comet assay is regarded as a sensitive
method for detecting DNA damage (Olive et al, 1990; Olive and
Banath, 1993; Ashby et al, 1995; Fairbairn et al, 1995). The major
advantage of the comet assay over other methods of measuring
DNA damage, such as pulse-field gel electrophoresis, step-graded
electrophoresis and alkaline filter elution, is that information is
gained about the distribution ofDNA damage and/orrepair among
individual cells within a cell population, providing an intercellular
distribution of damage. In addition, only a small number of cells
are required, allowing examination of a large number of experi-
mental conditions from a single-treated population ofcells. In the
alkaline version of the comet assay used here (Olive and Banath,
1993), cells with increased levels of DNA damage (single-strand
breaks, double-strand breaks and alkali-labile sites) after treatment
show extended migration ofthe DNA from the cell nucleus in the
presence ofa small electric current. Quantitation based on the size
and intensity ofthe comet tail provides a method ofcomparing the
effects ofdifferent treatments (Olive and Banath, 1993).
The aim of this study was to evaluate (1) the potential DNA-
damaging effects of low-dose PDT treatments with three photo-
sensitizers (haematoporphyrin derivative, methylene blue and
meso-tetrahydroxyphenylchlorin) and low-dose hyperthermia; (2)
the potential for cells to repair this damage, and (3) the use ofthe
comet assay for routine screening ofthese parameters.
MATERIALS AND METHODS
Cell culture
The cell line used for all these studies was the human myeloid
leukaemia cell line K562 obtained from the American Type
Culture Collection (ATCC). Cells were grown in RPMI medium,
supplemented with L-glutamine (2 mM), penicillin (100 IU ml-l),
streptomycin (0.1 mg ml-') and 10% horse serum (Biological
Industries, kibbutz beth haemek, Israel; batch 844713). All media
and supplements were obtained from Gibco, Paisley, UK.
Solutions of sensitizers
Methylene blue (MB) (Aldrich, Gillingham, Dorset, UK) was used
as purchased. A stock solution (0.374 mg ml-1) was made up in
distilled water and stored in the dark at 4°C until used. The sensi-
tizer was diluted to a concentration of 1.87 ,ug ml-' in growth
medium for the cell experiments. Haematoporphyrin derivative
(HpD) (batch 153) was purchased from Paisley Biochemicals
(Paisley, UK) as a stock solution of 5 mg ml-' in phosphate-
buffered saline (PBS). Aliquots ofthis stock at 100jig ml-' in PBS
were stored frozen until used. The sensitizer was diluted to a
concentration of 10 jg ml-' in medium for the cell experiments.
Meso-tetrahydroxyphenylchlorin (mTHPC) was kindly donated
by Scotia Pharmaceuticals, Guildford, Surrey, UK. The sensitizer
was dissolved in a solvent of ethanol-polyethylene glycol at a
concentration of 2 mg ml-1 and stored at 4°C in the dark. The
sensitizer was further diluted in PBS to produce a 100 ,ug m-1
stock and was diluted to a concentration of0.1Igg ml-1 in medium
for the cell experiments.
Survival after photodynamic therapy
All procedures were carried out in subdued lighting conditions.
Cells were suspended at a density of 5 x 105 ml-' in growth
medium, and sensitizer was added at the concentrations outlined
above. Cells were incubated for either 1 or 16 h and then pelleted
and resuspended in fresh growth medium to remove unbound
drug. These times were used for the MB-PDT treated samples to
ensure sufficient time had elapsed for any drug location in the
nucleus to occur. Cells were counted to enable plating at specific
densities after treatment and were aliquoted at appropriate cell
densities in Petri dishes for each light treatment. Light treatments
were performedusing a 20 W argon ionpumpeddye laser (Spectra
Physics, CA, USA), with the laser output of 20 mW cm-2 being
directed onto open 60-mm culture dishes using a fibre optic
system. The dose uniformity across the dish was ± 5%. Survival
curves were established using light doses of 0-2 J cm-2 [HpD
(630 nm) and mTHPC (655 nm)] and 0-20 J cm-2 [MB (664 nm)].
Cell survival was measured using a limiting dilution assay. Briefly,
treated cells were plated into 96-well plates (200 ,ul per well) and
incubated at 37'C in a 5% carbon dioxide-95% air atmosphere for
3 weeks. Separate plates were set up at two or three cell densities
per dose point. Plates were stained using 20 gl of lodonitro-
tetrazolium Violet stain (Sigma, Poole, Dorset, UK) and scored for
negative wells. Three independent survival experiments, each
comprising triplicate repeats, were performed. At least 10 discrete
dose points were used to define each curve. The drug concentra-
tion required to achieve 3% or 18% cell kill in combination with
light was determined for each drug from the mathematically
modelled survival data. This approach allowed a drug-PDT dose
regimen to be selected that gave a precise level ofcell kill, thereby
ensuring that the three photosensitizers could be compared at
equitoxic doses.
Table 1 PDT treatments given to achieve required level of cell kill
Treatment Dose Required level of cell kill (%)
Control 0
Hyperthermia 430C/6 min 3
Hyperthermia 43°C/30 min 18
HpD(10 gml-')(16h) 0
HpD (10 ug ml-') (16 h) 0.21 J cm-2 3
HpD (10 g ml-') (16 h) 0.53 Jcm-2 18
Light only 20 J cm-2 0
MB (5 x 10-5 mol dm-3) (1 h) - 0
MB (5 x 10-5 mol dm-3) (1 h) 20 J cm-2 18
MB (5 x 10-5 mol dm-3) (16 h) - 0
MB (5 x 10-5 mol dm-3) (16 h) 20 J cm-2 3
mTHPC (0.1 ug ml-') (16 h) - 0
mTHPC (0.1 gg ml-') (16 h) 0.17 J cm-2 3
mTHPC (0.1 gg ml-') (16 h) 0.41 J cm-2 18
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Survival curve analysis
Colony-forming efficiencies were calculatedby assuming aPoisson
distribution for the surviving cells per well and survival parameters
assessed using a single-hit-multitarget model adapted to incorpo-
rate a quenched-dose parameter, as described previously (West,
1989; Elyan et al, 1993). The slopes of the exponential portion of
the fitted survival curves (Do) were used to describe the data.
Survival after hyperthermia
Cells were counted and suspended at an appropriate density for
each dose point. Suspensions were placed in growth medium and
subjected to different doses of heat by submerging the cells in a
temperature-controlled water bath. Survival was assessed at 420C,
43°C and 44°C using eight time points up to 2 h to produce each
curve. Cell survival was assessed using the limiting dilution assay
as outlined above.
Ionizing irradiations
Cells were resuspended to 5 x 105 ml-] in tissue culture medium,
and 2 ml of this suspension was irradiated at room temperature
using a 137Cs gamma source at a dose rate of 3.1 Gy min-m. In all
cases, control (unirradiated) cells were sham irradiated and treated
identically to the irradiated cells.
Survival after ionizing radiation
Cells were counted and suspended at 5 x 105 cell ml-' forirradiation
at room temperature at a dose rate of 3.1 Gy min-'. Cell survival
was assessed using a limiting dilution assay as described above.
Table 2 Cell survival parameters for K562. Do units are J cm-2 for PDT and
min for HT
Treatment Details Do (±s.d.)
PDT HpD (1O,ug ml-1; 16 h) 0.456 (0.008) J cm-2
PDT mTHPC (0.1 gg ml-'; 16 h) 0.354 (0.136) J cm-2
PDT MB (5 gm; 16 h) 43.93 J cm-2
PDT MB (5gM; 1 h) 32.43 J cm-2
HT 420C 345 (396) min
HT 430C 71.0 (50.8) min
HT 440C 10.8 (1.65) min
Table 3 Mean percentage of positive fluorescent cells (n = 3, ± s.d.) for each
drug treatment
Treatment Single experiment Combined results
(mean ± s.d.) (n = 3, ± s.d.)
Control (no drug) 3.63 (0.71) 2.50 (2.01)
HpD 92.67 (0.75) 73.37 (22.32)
mTHPCa 6.31 (1.77) 3.51 (3.39)
MB (1-h incubation) 64.28 (0.16) 36.12 (32.5)
MB (16-h incubation) 68.74 (0.08) 43.75 (28.9)
aThese results are probably due to very low drug levels resulting in very low
fluorescence, rather than drug being absent (see text).
Treatment of samples for comet analysis
The dose required to achieve 3% or 18% cell kill for each treat-
ment was determined from clonogenic cell-survival curves
obtained as outlined above. All samples were protected from light
during the treatment procedures. Cells were suspended at appro-
priate densities and incubated with sensitizer (as outlined in Table
1) for 1 or 16 h and subsequently pelleted and resuspended in
fresh medium. Controls for no treatment, light only and sensitizer
only were included as appropriate, and, in addition, two cell
aliquots were irradiated with either 5-Gy (surviving fraction =
0.03 ± 0.008) or 10-Gy gamma radiation (surviving fraction =
3.63 x 10- ± 0.3 x 10-5) (137Cs gamma source) as an additional
positive control forDNA damage. Treated cells were placed on ice
to ensure no enzymatic-induced DNA damage nor repair could
occur immediately after treatment had been given. Half of the
treated cell population were analysed immediately for DNA
damage using the comet assay, while the remaining 50% of the
cells were returned to 37°C, 5% carbon dioxide-95% air for 4 h to
enable DNA repair to occur.
Unirradiated cells containing each drug were analysed for sensi-
tizer uptake by flow cytometry using both 630 nm excitation and
488 nm excitation. Fluorescence microscopy (612 nm) on
cytospun cells was also performed for HpD- and mTHPC-treated
cells. Cytospun MB-treatedcells were examined using bright-field
microscopy.
The alkaline comet assay
Following treatment, cells were suspended to 8 x 104 cells ml-' in
4°C phosphate-buffered saline (PBS). An aliquot of 0.5 ml of cell
suspension was mixed with 1.5 ml of pre-warmed (45°C) 1%
agarose, and 1 ml ofthe cell plus agarose mixture was applied to a
microscope slide precoated previously with 400gl of 1% agarose.
The slides were then placed on an ice-cold metal surface to
solidify. The agarose-cell plating procedure was carried out in
reduced light conditions. Once the agarose had set (2 min), the
slides were carefully submerged in 500 ml of a freshly prepared
4°C lysis solution of 30 mm sodium hydroxide, 1.2 M sodium
chloride, 2% dimethylsulphoxide (DMSO), 1% Triton X-100 for
60 min. Lysis was performed in the absence ofall light and on ice
to maintain a low temperature. Subsequently, the slides were
rinsed in a solution of30 mm sodium hydroxide, 2 mm EDTA for a
total of 60 min including four changes of buffer (4 x 15-min
washes) to remove residual sodium chloride. The slides were then
transferred to an electrophoresis tank containing 1150 ml ofa solu-
tion of30 mm sodium hydroxide, 2 mm EDTA, 2% DMSO at room
temperature. The electrophoresis and washing tanks are made of
black Perspex ensuring all light is excluded. Electrophoresis was
carried out for 25 min at 20 V (approximately 0.6 V cm-'). After
electrophoresis, the slides were rinsed by submerging in double-
distilled waterand then were stained with 2.5gg ml-' ofpropidium
iodide (PI) in 0.1 M sodium hydroxide for 60 min followed by a
30-min rinse in double-distilled water to remove unbound PI.
Slides were dried at room temperature and rehydrated by placing
in double-distilled water for 45 min to ensure similar treatments
were scored on the same day.
In each of the three independent experiments, 50 cells were
scored on two replicate slides to give a total of 100 cells scored per
treatmentperindividual experiment. Comets were analysed using a
Leitz Diaplan fluorescent microscope at 200 x magnification using
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Figure 1 Distribution of comet tail moments in an individual experiment among populations of unirradiated K562 cells (top panels, control) and cells irradiated
with 5 Gy (middle panels) or 10 Gy (bottom panels) of gamma rays. (A) Results from cells processed for comet analysis immediately after irradiation (initial level
of damage). (B) Results from cells given a 4-h incubation at 370C after radiation treatment (residual level of damage)
a Kinetic Imaging Komet system (Liverpool, UK) (Ashby et al,
1995). Tail moment was used as an index of DNA damage which
combines a measure ofthe length ofthe comet tail and the propor-
tion ofDNA to migrate into the tail (Olive and Bandth, 1993).
RESULTS
Survival
Table 2 lists theDo values for each ofthe treatments used. Clearly,
K562 cells are relatively sensitive to HpD-PDT and mTHPC-
PDT, exemplified by low Do values of 0.456 and 0.354 J cm-2
respectively, but more resistant to MB-PDT in comparison
[Do 43.93 J cm-2 (16-h drug incubation) and 32.43 J cm-2 (1-h drug
incubation)]. Using an F-test to compare the fitted survival curves,
no significant difference in the Do values were obtained following
the two MB drug incubation times (P = 1). K562 was also found to
be relatively resistant to hyperthermia treatments, as reported by
others (Mivechi and Rossi 1990), with 42°C resulting in virtually
no cell kill over a 2-h period (very high DO), 43°C resulting in a
small amount of cell kill (lower Do) and 44'C resulting in rela-
tively rapid cell kill (smallestDO).
Drug localization
The percentages of cells containing fluorescent drug as measured
by flow cytometry for a typical single experiment and for all
experiments combined are given in Table 3. Although some inter-
experimental variation is evident, repeats within each experiment
incurred standard deviations of less than 2%. Approximately
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Figure 2 Each panel shows the mean comet tail moment (± s.e.m.) scored from an individual experiment for 100 cells comprising two replicate slides. The
upper panels show the mean tail moments for populations of K562 cells exposed to ionizing radiation (IR) at the doses shown (C in all panels represents untreated cells) either immediately after radiation treatment (A) or after a 4-h incubation at 370C before comet analysis (B). The middle panels show the tail
moment data for equitoxic doses of the three drug-PDT conditions immediately after treatment (A) or 4 h after treatment (B). The lower panels show data from cells exposed to hyperthermia at 3% (H3%) or 18% (H18%) cell kill immediately after radiation treatment (A) or 4 h after treatment (B)
30-40% of MB-treated cells scored positive for methylene blue
fluorescence and more than 70% of HpD-treated cells scored
positive for staining by flow cytometry (Table 3). However this
method was not suitable for mTHPC because of very weak levels
of fluorescence. To complement the flow cytometry study,
cytospun K562 cells were examined using fluorescence
microscopy to localize the drug uptake (data not shown). HpD
showed predominantly cytoplasmic fluorescence with a weaker
staining in the nuclear region, possibly from the nuclear
membrane. The majority ofmTHPC-treated cells had diffuse fluo-
rescence throughout the cytoplasm, with no evidence of nuclear
staining. One hour exposures were required to photograph
the weak mTHPC fluorescence, which may explain the poor detec-
tion seen with flow cytometry. Bright-field microscopy of MB
localization showed a minority ofcells with nuclear staining, with
the large majority exhibiting cytoplasm staining.
DNA damage
As expected, y-irradiation caused DNA damage in K562 cells and
this damage was predominantly repaired after a 4-h incubation at
37°C (Figure 1). The mean levels ofDNA damage for K562 cells,
as measured by tail moment, from a typical experiment are given
in Figure 2. A statistically significant increase in mean tail
moment value was detected for cells exposed to 10 Gy compared
with untreated cells (P = 0.019). As expected, hyperthermia
caused no measurable DNA damage after treatments that caused
3% or 18% cell kill (Figure 2).
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Figure 3 Distribution of comet tail moment values scored from an individual experiment of K562 cells given equitoxic doses of PDT: untreated cells (Control),
HpD-PDT-treated cells, MB-PDT-treated cells or mTHPC-PDT-treated cells. (A) Results from cells processed for alkaline comet analysis immediately following
PDT (initial level of damage). (B) Results from cells given a 4-h incubation at 370C following PDT treatment (residual level of damage)
In contrast, DNA damage was seen immediately after some
PDT treatments (Figure 2). Figure 3 shows the range of tail
moment values from a typical single experiment for K562 cells
given equitoxic doses of the three photosensitizers. Significant
differences in tail moment distribution were seen after MB-PDT
when assessed immediately after treatment (A) but the broad range
of values were not evident 4 h after treatment (B). No significant
difference between initial and residual damage was detected for
HpD or mTHPC in this individual experiment.
The data from the complete experimental series are shown in
Figure 4. The mean comet tail moment values measured from MB-
PDT (3% kill, 40.83 ± 7.30; 18% kill, 39.18 ± 5.47) are similar to
those obtained for cells receiving 5 Gy of gamma irradiation
(41.74 ± 11.44). A significant level of DNA damage was detected
immediately after MB-PDT treatment, however this was not
evident after a 4-h period ofincubation at 37°C. As no significant
DNA damage was seen after light-only or drug-only treatments,
these data imply that the DNA damage seen immediately after
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Figure 4 Mean comet tail moment (+ s.e.m.) from the three independent experiments. (A) Results for cells processed immediately after treatment (initial
damage). (B) Results obtained from cells incubated for 4 h at 370C immediately after treatment (residual damage). In all panels, C represents untreated cells. In
the HpD, mTHPC and MB panels, L represents cells exposed to light only, D represents cells exposed to drug only and the hatched bars represent cells given
HpD-PDT, mTHPC-PDT or MB-PDT at a level to achieve either 3% [P(3%)] or 18% [P(18%)] cell kill. In the lower panels (IR), the hatched bars represent cells
exposed to 5 or 10 Gy of y-rays
MB-PDT reflects damage caused by the light and photosensitizer
given in tandem and that the cells are capable of repairing this
damage. No significant differences were observed between the two
methylene blue incubation times, suggesting that the drug levels in
the nuclear region did not vary greatly between 1 h and 16 h of
incubation.
When the data from the three independent experiments were
combined, some DNA damage, as indicated by the larger tail
moment values, was evident following HpD-PDT at the largest
dose given (18% cell kill), although less than that seen after MB-
PDT. After a 4-h incubation at 37°C the DNA damage detected
immediately after HpD-PDT was not evident and tail moment
values were indistinguishable from that seen in untreated cells,
light-only or drug-only treatments. No significant DNA damage
was detected immediately after mTHPC-PDT compared with
untreated, light-only or drug-only treated cells.
DISCUSSION
While DNA damage after hyperthermia seems unlikely (Warters
and Stone, 1983), the potential for genotoxic damage during PDT
exists. However, this potential is likely to be relatively low
compared with ionizing radiation, as the damage reported consists
predominantly of oxidative damage to guanine leading to single-
strand breaks or an alkali-labile site, which are likely to be
relatively easily repaired and also are likely to be highly drug
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dependent (Moan et al, 1989). It has been established that a range
ofphotosensitizers produce similar types of DNA damage in cell-
free systems, proposed to result predominantly from singlet
oxygen (Epe et al, 1993). However, in cells, as singlet oxygen has
a short lifetime, it is to be expected that the subcellular target for
damage is likely to be restricted to sites close to the site of local-
ization of the sensitizer (Moan, 1990). These suggestions are now
largely supported by the results reported here using the comet
assay as a measure of initial DNA damage and repair (Figure 2):
hyperthermia treatments resulted in no detectable DNA damage in
K562; PDT treatments resulted in a range ofDNA damage effects
that were dependent on the photosensitizer used.
The difference in the distribution oftail moment values between
the initial damage profiles measured immediately after treatment
(Figure 1A) and residual damage profiles scored after an incuba-
tion period at 37°C (Figure 1B) is regarded as indicative of DNA
repair (Olive et al, 1990; Olive and Banath 1993; Fairbaim et al,
1995). The results in Figures 1 and 2 indicate that DNA damage
induced after 5 Gy and 10 Gy of ionizing radiation is predomi-
nantly repaired, as would be expected because the alkaline comet
assay scores primarily single-strand breaks (ssbs) and alkaline-
labile sites. These lesions are not considered to be long lasting, are
rapidly repaired and are unlikely to lead to cell death (Ward 1991).
Our data (albeit from the very limited dose range studied) are
compatible with a linear response between radiation dose and
initial DNA damage as seen by others (Wlodek and Olive, 1992).
The results presented in Figures 3 and 4 indicate that MB-PDT and
to a lesser extent HpD-PDT both cause DNA damage, however
this is repaired and not evident for either treatment when assessed
4 h later. MB-PDT produces an equivalent level of DNA damage
to that seen after 5 Gy ofy-rays, approximately 5000 ssbs per cell
(Ward, 1988); HpD-PDT produces much less damage. These
lesions are generally regarded as non-lethal and were seen to be
repaired within 4 h (Figures 2 and 4). Although DNA damage was
detected after HpD-PDT and MB-PDT, it is unlikely that this
directly causes cell death on treatment, however the possibility
remains that the damage is incorrectly repaired (which can not be
assessed by the comet assay), presenting the possibility that muta-
tions in DNA may arise after MB-PDT or HpD-PDT.
The distribution of tail moment values in Figures 1 and 3 indi-
cate that not all cells are equally damaged after photodynamic
therapy. This may reflect the uptake ofphotosensitizer on a cell by
cell basis. Indeed, the flow cytometric analysis performed did
show a distribution of sensitizer uptake in the cases of HpD and
MB, with some cells in each population appearing to contain no
sensitizer (Table 3).
The low level of DNA damage that was observed after the
higher dose HpD-PDT is in strong agreement with a number of
previous studies. For example, Penning and colleagues (1994b)
reported that for L929 fibroblasts a small amount ofDNA damage
occurred immediately after PDT. These authors also observed that
HpD-PDT inactivated some DNA-repair enzymes, which they
suggested might lead to difficulties in DNA repair. In contrast, our
results in K562 leukaemia cells showed no residual DNA damage
in the HpD-PDT treated K562 cells after4 h ofincubation to allow
for repair.
In comparison with HpD-PDT, MB-PDT was observed to
induce a relatively large level of DNA damage, which was signifi-
cantly greater than that of either the light-only (Student t-test; P =
0.031) or drug-only controls (P = 0.009) (Figure 4). This again
agrees with literature evidence that methylene blue plus light
induces DNA damage in the form of 8-hydroxyguanine formation
(Buchko et al, 1995). No significant differences were observed
between the 1-h and 16-h drug incubations, suggesting that the
drug localizes rapidly in the nuclear region ofthe cells - an obser-
vation that broadly agrees with the limited microscopy evidence
obtained in this study and with literature evidence. Methylene blue
and other dyes of this structure have been reported to intercalate
rapidly into DNA, binding predominantly to purine nucleotides
(Tuite and Kelly, 1995). However, in our study, no residual DNA
damage in MB-PDT-treated cells was observed after 4 hours'
repair. This is supported by the report ofWagner et al (1995) that
no genotoxic effects were observed in vivo after MB-PDT, consis-
tent with efficient repair of these lesions. However, other studies
have implicated 8-hydroxyguanine in spontaneous mutagenesis,
carcinogenesis and cellular ageing (Musarrat and Wani, 1994).
Such discrepancies might arise from the degree of fidelity of the
DNA repair, which has not been assessed in this study. Further
experiments would be required using a repair fidelity assay (e.g.
Powell and McMillan, 1994) to investigate this in more detail.
In contrast to the other two photosensitizers studied, mTHPC-
PDT resulted in no DNA damage as measured by the comet assay.
This is in agreement with the limited literature evidence that
relates to localization site (Ma et al, 1994), which would suggest
that this drug would not result in DNA damage on activation
because the drug is not in the proximity of the nucleus. However,
no reported studies exist to our knowledge to confirm the comet
assay results for mTHPC.
CONCLUSIONS
The comet assay has been previously found applicable to
screening large numbers of individuals to determine the extent of
DNA damage in human lymphocytes (Betti et al, 1995). We
propose that the assay is also suitable for screening DNA damage
after PDT and thermal laser treatments and offers some advan-
tages over existing methods of measuring DNA damage. As no
detectable DNA damage was evident after m-THPC-PDT, these
preliminary dataimply that this agent is the least likely ofthe three
photosensitizers examined to cause mutagenesis in the K562 cell
line. Future studies will concentrate on the rate of and fidelity of
these repair processes.
ACKNOWLEDGEMENTS
The authors thank the Medical Research Council, the Association
for International Cancer Research and the Cancer Research
Campaign for financial support; also staff and customers at Asda,
Chadderton, UK for funds to purchase the image analysis system.
The assistance ofMr M Hughes and MrJ Barry in carrying out the
flow cytometric measurements is acknowledged. We particularly
thank Dr Peggy Olive (Medical Biophysics, British Colombia
Cancer Research Centre, Vancouver, Canada) for help and guid-
ance with the comet assay studies.
REFERENCES
Ashby J, Tinwell H, Lefevre PA and Browne MA (1995) The single cell gel
electrophoresis assay for induced DNA damage (comet assay): measurement of
tail length and moment. Mutagenesis 10: 85-90
Bachmann B, Knuverhopf J, Lambrecht B and Mohr H (1995) Target structures for
HIV-1 inactivation by methylene blue and light. J Med Virol 47: 172-178
British Journal ofCancer(1997) 75(12), 1721-1729 C Cancer Research Campaign 1997DNA damage and repairafter PDT 1729
Betti C, Davini T, Giannessi L, Loprieno N and Barale R (1995) Comparative
studies by comet test and SCE analysis in human lymphocytes from 200
healthy subjects. Mutat Res 343: 201-207
Black AR and Subjeck JR (1989) Involvement ofthe rRNA synthesis in the
enhanced survival and recovery ofprotein synthesis seen in thermotolerance.
J Cell Physiol 138: 439-449
Blazek ER and Hariharan PV (1984) Alkaline elution studies ofhematoporphyrin-
derivative photosensitized DNA damage and repair in Chinese hamster ovary
cells. Photochem Photobiol 40: 5-13
Boegheim JP, Dubbelman TM, Mulldenders LH and Van-Steveninck J (1987)
Photodynamic effects ofhaematoporphyrin derivative on DNA repair in murine
L929 fibroblasts. Biochem J 244: 711-715
Bonnet R and Berenbaum M (1989) Porphyrins as photosensitizers. In
Photosensitizing Compounds: Their Chemistry, Biology and Clinical Use. Bock
G and Harnett S (eds) Ciba Foundation Symposium 146, J Wiley: Chichester,
UK pp 40-59
Brown SB (1996) PDT comes ofage. International Photodynamics 1: I
Buchko GW, Wagner JR, Cadet J, Raoul S and Weinfeld M (1995) Methylene blue-
mediated photooxidation of7,8-dihydro-8-oxo-2'-deoxyguanosine. Biochim
Biophys Acta 1263: 17-24
Dickson JA and Calderwood SK (1979) Effects ofhyperglycemia and hyperthermia
on the pH, glycolysis and respiration ofthe Yoshida sarcoma in vivo. JNatl
Cancer Inst 63: 1371-1381
Elyan SAG, West CML, Roberts SA and Hunter RD (1993) Use of low-dose rate
irradiation to measure the intrinsic radiosensitivity ofhuman T-lymphocytes.
IntJRadiat Biol 94: 375-383
Epe B, Pflaum M and Boiteux S (1993) DNA damage induced by photosensitizers in
cellular and cell-free systems. Mutat Res 299: 135-145
Fairbaim DW, Olive PL and O'Neill KL (1995) The comet assay: a comprehensive
review. Mutat Res 339: 37-59
Fowler GJS, Rees RC and Devonshire R (1990) The photokilling ofbladder
carcinoma cells in vitro by phenothiazine dyes. Photochem Photobiol 52:
489-494
Gomer CJ (1978) Evaluation of in vivo tissue localization properties and in vitro
photosensitization reactions ofhematoporphyrin derivative. PhD Dissertation,
State University ofNew York at Buffalo.
Konings AWT (1988) Membranes as targets for hyperthermic cell killing. In Recent
Results in Cancer Research, Vol. 109, Hinkelbein W, Bruggmoser G,
Engelhardt R and Wannenmacher M. (eds), pp. 9-21. Springer-Verlag: Berlin
Lepcock JR and Kruuv J (1992) Mechanisms ofthermal cytotoxicity. In
Hyperthermic Oncology, Vol 2, Gemer EW and Cetas TC. (eds), pp. 9-16.
Arizona board ofregents: Tuscon, USA
Levy JG (1995) Photodynamic therapy. Trends Biotechnol 13: 14-18
Ma L, Moan J and Berg K (1994) Evaluation ofa new photosensitizer, meso-tetra-
hydroxyphenyl-chlorin, for use in photodynamic therapy: a comparison ofits
photobiological properties with those oftwo other photosensitizers. Int J
Cancer 57: 883-888
Marcus SL (1992) Clinical photodynamic therapy: the continuing evolution. In
Photodynamic therapy. Basic Principles and Clinical Applications. Henderson
BW and Dougherty TJ. (eds), pp. 219-268. Dekker: New York
Mivechi NF and Rossi JJ (1990) Use of polymerase chain reaction to detect the
expression ofthe Mr 70,000 heat shock genes in control or heat shock
leukemic cells as correlated to their heat response. Cancer Res 50:
2877-2884
Moan J (1990) On the diffusion length of singlet oxygen in cells and tissues.
JPhotochem Photobiol B Biol 6: 343-347
Moan J, Berg K, Kvam E, Western A, Malik Z, Rock A and Schneckenburger H
(1989) Intracellular localization ofphotosensitizers. In Ciba Foundation
Symposium 146, Wiley, Chichester, pp 95-111
Mussarat J and Wani AA (1994) Quantitative immunoanalysis ofpro-mutagenic 8-
hydroxy-2'-deoxyguanosine in oxidized DNA. Carcinogenesis 15: 2037-2043
Norden B and Tjemeld F (1982) Structure ofmethylene blue-DNA complexes
studied by linear and circular dichroism spectroscopy. Biopolymers 21:
1713-1734
Olive PL and Banath JP (1993) Induction and rejoining ofradiation induced DNA
single-strand breaks: tail moment as a function ofposition in the cell cycle.
Mutat Res (DNA repair) 294: 275-283
Olive PL, Banath JP and Durand RE (1990) Heterogeneity in radiation-induced
DNA damage and repair in tumour and normal cells measured using the comet
assay. Radiat Res 122: 86-94
Penning LC, Tijssen K, Boegheim JPJ, Vansteveninck J and Dubbelman TMAR
(I994a) Relationship between photodynamically induced damage to various
cellular-parameters and loss ofclonogenicity in different cell-types with
hematoporphyrin derivative as sensitizer. Biochim Biophys Acta 1221: 250-258
Penning LC, Lagerberg JWM, Vandierendonck JH, Comelisse CJ, Dubbelman
TMAR and Vansteveninck J (1994b) The role of DNA damage and inhibition
ofpoly(ADP-ribosyl)ation in loss ofclonogenicity of murine L929 fibroblasts,
caused by photodynamically induced oxidative stress. Cancer Res 54:
5561-5567
Powell SN and McMillan TJ (1994) The repair fidelity ofrestriction enzyme induced
double strand breaks in plasmid DNA correlates with radioresistance in human
tumour cell lines. Int JRadiat Oncol Biol Phys 29: 1035-1040
Roti Roti JL and Laszlo A (1988) The effects ofhyperthermia on cellular
macromolecules. In Hyperthermia and Oncology, Vol. 1, Urano M. (ed.),
pp. 13-56. VSP: Zeist, The Netherlands
Tuite E and Kelly JM (1995) The interaction of methylene blue, azure B and
thionine with DNA - formation ofcomplexes with polynucleotides and
mononucleotides as model systems. Biopolymers 35: 419-433
Wagner SJ, Cifone MA, Murli H, Dodd RY and Myhr B (1995) Mammalian
genotoxicity assessment ofmethylene blue in plasma - implications for virus
inactivation. Transfusion 35: 407-413
Warters RL and Stone OL (1983) Macromolecule synthesis in HeLa cells after
thermal shock. Radiat Res 96: 646-652
Ward JF (1988) DNA damage produced by ionising radiation damage in mammalian
cells: identities, mechanisms of formation and repairability. Progr Nuclear Acid
Res Molec Biol 35: 95-125
Ward JF (1991) DNA damage and repair. Basic Life Sci 58: 403-415
Welch WJ and Suhan JP (1985) Morphological study ofthe mammalian stress
response: characterization ofchanges in cytoplasmic organelles, cytoskeleton
and nucleoli and appearance ofintra-nuclear actin filaments. J Cell Biol 101:
1198-1211
West CML (1989) Size-dependent resistance ofhuman spheroids to photodynamic
treatment. Br J Cancer 59: 510-514
Whitehurst C and Moore JV (1995) Development of an alternative light source for
biomedical applications. SPIE Proc 2629: 291-298
Wlodek D and Olive PL (1992) Neutral filter elution detects differences in
chromatin organization which can influence cellular radiosensitivity. Radiat
Res 132: 242-247
C Cancer Research Campaign 1997 British Journal of Cancer (1997) 75(12), 1721-1729